Plexus (NASDAQ:PLXS) Issues Q4 2026 Earnings Guidance

Plexus (NASDAQ:PLXS) updated its fourth quarter 2026 earnings guidance on Wednesday. The company provided earnings per share guidance of 2.470-2.630 for the period, compared to the consensus earnings per share estimate of 2.090. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.3 billion.

Plexus Price Performance

NASDAQ PLXS traded down $9.59 during trading on Wednesday, hitting $240.49. 825,119 shares of the stock traded hands, compared to its average volume of 336,020. The company has a quick ratio of 0.74, a current ratio of 1.54 and a debt-to-equity ratio of 0.06. Plexus has a 12-month low of $124.49 and a 12-month high of $307.06. The firm has a 50-day simple moving average of $274.29 and a 200-day simple moving average of $232.49. The company has a market capitalization of $6.44 billion, a P/E ratio of 35.16 and a beta of 0.88.

Plexus (NASDAQ:PLXS) last issued its quarterly earnings data on Wednesday, July 29th. The technology company reported $1.58 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.13 by ($0.55). The firm had revenue of $1.30 billion for the quarter, compared to analysts’ expectations of $1.23 billion. Plexus had a return on equity of 12.84% and a net margin of 4.35%.During the same period last year, the company earned $1.64 earnings per share. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS. As a group, analysts predict that Plexus will post 5.98 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on PLXS. Stifel Nicolaus upped their price target on shares of Plexus from $280.00 to $330.00 and gave the company a “buy” rating in a research note on Monday, June 22nd. Raymond James Financial reissued an “outperform” rating and issued a $275.00 price objective on shares of Plexus in a research note on Thursday, April 30th. Weiss Ratings upgraded shares of Plexus from a “buy (b-)” rating to a “buy (b)” rating in a report on Monday, July 6th. Zacks Research upgraded shares of Plexus from a “strong sell” rating to a “hold” rating in a research report on Monday, July 13th. Finally, Needham & Company LLC increased their price target on shares of Plexus from $285.00 to $310.00 and gave the company a “buy” rating in a report on Monday, June 1st. Five analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, Plexus currently has a consensus rating of “Moderate Buy” and a consensus price target of $246.67.

Insider Buying and Selling

In related news, insider Victor (Pang Hau) Tan sold 3,000 shares of the stock in a transaction on Monday, May 11th. The stock was sold at an average price of $271.23, for a total transaction of $813,690.00. Following the sale, the insider owned 10,457 shares in the company, valued at approximately $2,836,252.11. This represents a 22.29% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Todd P. Kelsey sold 1,500 shares of the firm’s stock in a transaction on Wednesday, June 17th. The stock was sold at an average price of $294.98, for a total value of $442,470.00. Following the completion of the sale, the chief executive officer owned 68,888 shares of the company’s stock, valued at approximately $20,320,582.24. This represents a 2.13% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 20,481 shares of company stock worth $5,519,183. 1.78% of the stock is currently owned by corporate insiders.

More Plexus News

Here are the key news stories impacting Plexus this week:

• Positive Sentiment: Quarterly results exceeded expectations. Plexus reported non-GAAP EPS of $2.32, beating consensus by $0.18, while revenue reached approximately $1.30 billion—about $80 million above estimates. Revenue increased 28.1% year over year to $1.31 billion, and gross profit rose 27.2% to $131.4 million. Plexus Non-GAAP EPS and Revenue Results
• Positive Sentiment: Fourth-quarter guidance was well above earnings expectations. Management forecast EPS of $2.47–$2.63, compared with the $2.09 analyst consensus, and projected revenue of $1.3–$1.4 billion. The outlook suggests continued demand and potentially improving profitability. Plexus Fiscal Third Quarter Financial Results
• Positive Sentiment: Operating profit rose 14.3% to $61.3 million, while cash and equivalents increased 32.2% year over year to $314.1 million. Recent analyst coverage also remains favorable, with a median price target of $310 and targets as high as $330, although these estimates may not yet reflect the latest results. Plexus Stock and Q3 2026 Earnings
• Neutral Sentiment: Despite higher revenue and operating profit, net income attributable to common shareholders declined 4.7% to $43.0 million, and diluted GAAP EPS fell to $1.58. Total liabilities rose to $2.1 billion, while operating cash flow of $25.9 million was roughly offset by $26.7 million of capital spending.
• Negative Sentiment: Insiders reported 43 open-market sales and no purchases over the past six months, including substantial sales by the CEO and other senior executives. This may raise valuation or confidence concerns, particularly after the stock’s strong longer-term advance. Plexus Insider Trading Activity

Hedge Funds Weigh In On Plexus

A number of large investors have recently made changes to their positions in PLXS. Johnson Financial Group Inc. purchased a new stake in Plexus in the 3rd quarter worth about $72,000. EverSource Wealth Advisors LLC boosted its position in shares of Plexus by 583.3% during the second quarter. EverSource Wealth Advisors LLC now owns 574 shares of the technology company’s stock valued at $78,000 after buying an additional 490 shares during the period. Kemnay Advisory Services Inc. bought a new position in shares of Plexus during the fourth quarter valued at approximately $88,000. Smartleaf Asset Management LLC grew its stake in shares of Plexus by 13.6% during the fourth quarter. Smartleaf Asset Management LLC now owns 916 shares of the technology company’s stock valued at $137,000 after buying an additional 110 shares during the last quarter. Finally, Corient Private Wealth LLC purchased a new stake in shares of Plexus in the second quarter worth approximately $210,000. 94.45% of the stock is owned by hedge funds and other institutional investors.

Plexus Company Profile

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.